Congenital heart malformations, also known as congenital heart defects (CHDs), encompass a spectrum of structural abnormalities in the heart that manifest at birth, originating during fetal development. These defects impact various components of the heart, including its walls, valves, and blood vessels, leading to disruptions in normal blood flow. The severity of CHDs can vary, with some posing minimal health risks while others demand immediate medical attention. The etiology of congenital heart malformations is multifaceted, involving a complex interplay of genetic factors, environmental influences, or a combination thereof. Recent strides in medical technology have revolutionized the landscape of prenatal screening, enabling the early detection of congenital heart malformations. This breakthrough facilitates timely intervention and treatment strategies, ultimately enhancing patient outcomes. Treatment approaches are diverse, tailored to the specific defect and its severity. They range from pharmaceutical interventions to intricate surgical procedures aimed at rectifying the structural anomalies.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt